<?xml version="1.0" encoding="UTF-8"?>
<p>Taken together, the results obtained in this study suggest that GenoTX-407, the combination of SBR and MOB, is a potential drug candidate exerting antioxidant and anti-inflammatory effects via the Nrf2/HO-1 and NF-ÎºB signaling pathways and insights gleaned from these studies could lead to the development of novel combination drug therapies for the treatment of various diseases</p>
